Bio Rad Laboratories Inc/ US0905722072 /
| 2024-04-18 10:10:00 PM | Chg. -9.84 | Volume | Bid2024-04-18 | Ask2024-04-18 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 281.02USD | -3.38% | 373,365 Turnover: 49.95 mill. |
265.80Bid Size: 200 | 294.00Ask Size: 100 | 6.58 bill.USD | - | - |
Assets
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 437.6900 | 488.6140 | 493.4960 | 508.6900 | 499.3390 | ||||||
| Intangible Assets | 214.0260 | 161.6090 | 174.1130 | 133.1230 | 145.5000 | ||||||
| Long-Term Investments | 719.8400 | 830.7900 | 1,027.7360 | 2,655.7090 | 4,638.2050 | ||||||
| Fixed Assets | 1,933.9460 | 2,005.9800 | 2,296.3510 | 3,587.6220 | 5,828.7450 | ||||||
| Inventories | 490.2240 | 524.9610 | 594.8040 | 583.8150 | 554.0070 | ||||||
| Accounts Receivable | 391.4850 | 372.3480 | 464.8470 | 392.4430 | 392.6720 | ||||||
| Cash and Cash Equivalents | 457.5490 | 456.2640 | 383.8240 | 431.5260 | 660.6720 | ||||||
| Current Assets | 1,777.5960 | 1,844.5240 | 1,976.6490 | 2,023.4780 | 2,180.1550 | ||||||
| Total Assets | 3,711.5420 | 3,850.5040 | 4,273 | 5,611.1000 | 8,008.9000 | ||||||
Liabilities
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 122.3910 | 133.1090 | 135.1820 | 122.4500 | 107.0140 | ||||||
| Long-term debt | 435.7070 | 434.1860 | 434.6000 | 438.9000 | 13.6000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 233.5000 | 222.9000 | 222.2000 | 553.2000 | 997.8000 | ||||||
| Liabilities | 1,221.0390 | 1,263.7450 | 1,342.7500 | 1,590.7690 | 2,253.8430 | ||||||
| Share Capital | .0020 | .0020 | .0020 | .0020 | .0020 | ||||||
| Total Equity | 2,490.5030 | 2,586.7590 | 2,930.2500 | 4,020.3310 | 5,755.0570 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 3,711.5420 | 3,850.5040 | 4,273 | 5,611.1000 | 8,008.9000 | ||||||
Income Statement
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,019.4410 | 2,068.1720 | 2,160.2000 | 2,289.4150 | 2,311.6590 | ||||||
| Depreciation (total) | - | - | - | 138.1000 | 134.2000 | ||||||
| Operating Result | 166.7080 | 53.1940 | 116.6500 | -103.3410 | 229.6610 | ||||||
| Interest Income | 21.6920 | 21.9420 | 21.9140 | -23.9620 | -23.4160 | ||||||
| Income Before Taxes | 145.8470 | 41.5600 | 97.8000 | 512.7000 | 2,261.1000 | ||||||
| Income Taxes | -32.7540 | -13.4350 | 24.4000 | -147 | -502.4000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 113.0930 | 28.1250 | 122.2000 | 365.6000 | 1,758.7000 | ||||||
Per Share
Cash Flow
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 186.2100 | 216.4330 | 103.9000 | 285.5000 | 457.9000 | ||||||
| Cash Flow from Investing Activities | -166.8690 | -213.8800 | -175.5720 | -186.9780 | -208.8890 | ||||||
| Cash Flow from Financing | 8.5810 | 9.0200 | .3410 | -48.6800 | -22.7580 | ||||||
| Decrease / Increase in Cash | 44.2980 | -1.2850 | -72.4400 | 49.1810 | 228.4870 | ||||||
| Employees | 7,700 | 8,250 | 8,150 | 8,260 | 8,120 | ||||||
